Company
Chemomab
Chemomab Therapeutics is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need
Also known as Chemomab Therapeutics, Chemomab Therapeutics Ltd.
- Status
- Operatingas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Founded
- 2011
- Legal name
- Chemomab Therapeutics Ltd.
Claim, correct or request removal
Record updated 28 September 2026
About
Chemomab Therapeutics is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need
Funding snapshot
- Total raised
- $55.4MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $10M2024-07-29
Funding rounds
- Round, 2024
- $10M2024-07-29, SEC form D sold, 10 investors
- Round, 2021
- $45.4M2021-03-16, SEC form D sold, 26 investors
Products
- Other
- Nebokitug (CM-101)
Loading relationship preview